RA CAPITAL MANAGEMENT, L.P.
Q2 2023 13F-HR Holdings
Net value change ($000)
+879,060
(19.9%)
New positions
5
Sold out positions
9
Turnover %
7.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| LEGN | 314,978 | 268.1% |
| ASND | 255,914 | 34.3% |
| DICE Therapeutics, Inc. | 139,926 | 62.2% |
| PCVX | 120,813 | 44.2% |
| AXSM | 71,860 | NEW |
| FDMT | 55,466 | NEW |
| NAMS | 53,970 | 101.8% |
| 89bio, Inc. | 42,471 | 24.4% |
| CVAC | 42,249 | 49.5% |
| RXST | 37,000 | 72.7% |
Top Reduces (Value $000, Stocks/ETFs)
| BELLUS Health Inc. | -91,034 | -100.0% |
| CLDX | -62,424 | -100.0% |
| VOR | -52,095 | -42.6% |
| ImmunoGen, Inc. | -39,953 | -47.6% |
| HilleVax, Inc. | -29,093 | -100.0% |
| RNAM | -27,336 | -27.8% |
| PEPG | -26,754 | -26.9% |
| Kinnate Biopharma Inc. | -26,651 | -100.0% |
| JBIO | -24,958 | -15.0% |
| RCKT | -19,387 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|